Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ENSC Ensysce Biosciences Inc
- Stocks
- Healthcare
- NASDAQ: ENSC
Price (delayed)
$2.38
Market cap
$5.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$6.54
Enterprise value
$2.85M
Highlights
The company's EPS has surged by 88% YoY and by 43% QoQ
ENSC's net income is up by 41% year-on-year and by 15% since the previous quarter
ENSC's quick ratio is down by 18% YoY but it is up by 7% from the previous quarter
Ensysce Biosciences's debt has decreased by 15% from the previous quarter but it has increased by 4.6% YoY
The equity has contracted by 19% YoY and by 18% from the previous quarter
Key stats
What are the main financial stats of ENSC
Market
Valuations
Earnings
Shares outstanding
2.37M
Market cap
$5.64M
Enterprise value
$2.85M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.1
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$6.85M
Net income
-$6.82M
EBIT
-$6.77M
EBITDA
-$6.77M
Free cash flow
-$5.8M
Per share
Balance sheet
Liquidity
EPS
-$6.54
EPS diluted
-$6.54
Free cash flow per share
-$4.14
Book value per share
$2.17
Revenue per share
$0
TBVPS
$3.29
Total assets
$4.61M
Total liabilities
$1.89M
Debt
$257,383
Equity
$3.05M
Working capital
$2.64M
Debt to equity
0.08
Current ratio
2.5
Quick ratio
1.75
Net debt/EBITDA
0.41
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-121.8%
Return on equity
-176.2%
Return on invested capital
-683.5%
Return on capital employed
-237.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ENSC stock price
How has the Ensysce Biosciences stock price performed over time
Intraday
3.48%
1 week
5.31%
1 month
-7.39%
1 year
-72.23%
YTD
-70.76%
QTD
-7.03%
Financial performance
How have Ensysce Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.85M
Net income
-$6.82M
Gross margin
N/A
Net margin
N/A
ENSC's net income is up by 41% year-on-year and by 15% since the previous quarter
Ensysce Biosciences's operating income has increased by 31% YoY
Price vs fundamentals
How does ENSC's price correlate with its fundamentals
Growth
What is Ensysce Biosciences's growth rate over time
Valuation
What is Ensysce Biosciences stock price valuation
P/E
N/A
P/B
1.1
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 88% YoY and by 43% QoQ
The price to book (P/B) is 31% lower than the last 4 quarters average of 1.6
The equity has contracted by 19% YoY and by 18% from the previous quarter
Efficiency
How efficient is Ensysce Biosciences business performance
ENSC's return on equity has surged by 66% year-on-year and by 11% since the previous quarter
The company's return on assets has surged by 54% YoY and by 13% QoQ
Ensysce Biosciences's return on invested capital has decreased by 7% QoQ
Dividends
What is ENSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ENSC.
Financial health
How did Ensysce Biosciences financials performed over time
Ensysce Biosciences's total assets is 144% higher than its total liabilities
Ensysce Biosciences's total assets has decreased by 18% QoQ and by 9% YoY
ENSC's quick ratio is down by 18% YoY but it is up by 7% from the previous quarter
Ensysce Biosciences's debt is 92% less than its equity
The equity has contracted by 19% YoY and by 18% from the previous quarter
Ensysce Biosciences's debt has decreased by 15% from the previous quarter but it has increased by 4.6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.